IL-27 Counteracts Neuropathic Pain Development Through Induction of IL-10
Neuroimmune-glia interactions have been implicated in the development of neuropathic pain. Interleukin-27 (IL-27) is a cytokine that presents regulatory activity in inflammatory conditions of the central nervous system. Thus, we hypothesized that IL-27 would participate in the neuropathic pain proce...
Saved in:
Published in | Frontiers in immunology Vol. 10; p. 3059 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
28.01.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Neuroimmune-glia interactions have been implicated in the development of neuropathic pain. Interleukin-27 (IL-27) is a cytokine that presents regulatory activity in inflammatory conditions of the central nervous system. Thus, we hypothesized that IL-27 would participate in the neuropathic pain process. Here, we found that neuropathic pain caused by peripheral nerve injury (spared nerve injury model; SNI), was enhanced in IL-27-deficient
mice, whereas nociceptive pain is similar to that of wild-type mice. SNI induced an increase in the expression of IL-27 and its receptor subunit (
) in the sensory ganglia and spinal cord. IL-27 receptor was expressed mainly in resident macrophage, microglia, and astrocytes of the sensory ganglia and spinal cord, respectively. Finally, we identify that the antinociceptive effect of IL-27 was not observed in IL-10
mice. These results provided evidence that IL-27 is a cytokine produced after peripheral nerve injury that counteracts neuropathic pain development through induction of the antinociceptive cytokine IL-10. In summary, our study unraveled the role of IL-27 as a regulatory cytokine that counteracts the development of neuropathic pain after peripheral nerve damage. In conclusion, they indicate that immunotherapies based on IL-27 could emerge as possible therapeutic approaches for the prevention of neuropathic pain development after peripheral nerve injury. |
---|---|
AbstractList | Neuroimmune-glia interactions have been implicated in the development of neuropathic pain. Interleukin-27 (IL-27) is a cytokine that presents regulatory activity in inflammatory conditions of the central nervous system. Thus, we hypothesized that IL-27 would participate in the neuropathic pain process. Here, we found that neuropathic pain caused by peripheral nerve injury (spared nerve injury model; SNI), was enhanced in IL-27-deficient
mice, whereas nociceptive pain is similar to that of wild-type mice. SNI induced an increase in the expression of IL-27 and its receptor subunit (
) in the sensory ganglia and spinal cord. IL-27 receptor was expressed mainly in resident macrophage, microglia, and astrocytes of the sensory ganglia and spinal cord, respectively. Finally, we identify that the antinociceptive effect of IL-27 was not observed in IL-10
mice. These results provided evidence that IL-27 is a cytokine produced after peripheral nerve injury that counteracts neuropathic pain development through induction of the antinociceptive cytokine IL-10. In summary, our study unraveled the role of IL-27 as a regulatory cytokine that counteracts the development of neuropathic pain after peripheral nerve damage. In conclusion, they indicate that immunotherapies based on IL-27 could emerge as possible therapeutic approaches for the prevention of neuropathic pain development after peripheral nerve injury. Neuroimmune–glia interactions have been implicated in the development of neuropathic pain. Interleukin-27 (IL-27) is a cytokine that presents regulatory activity in inflammatory conditions of the central nervous system. Thus, we hypothesized that IL-27 would participate in the neuropathic pain process. Here, we found that neuropathic pain caused by peripheral nerve injury (spared nerve injury model; SNI), was enhanced in IL-27-deficient (−/−) mice, whereas nociceptive pain is similar to that of wild-type mice. SNI induced an increase in the expression of IL-27 and its receptor subunit ( Wsx1 ) in the sensory ganglia and spinal cord. IL-27 receptor was expressed mainly in resident macrophage, microglia, and astrocytes of the sensory ganglia and spinal cord, respectively. Finally, we identify that the antinociceptive effect of IL-27 was not observed in IL-10 −/− mice. These results provided evidence that IL-27 is a cytokine produced after peripheral nerve injury that counteracts neuropathic pain development through induction of the antinociceptive cytokine IL-10. In summary, our study unraveled the role of IL-27 as a regulatory cytokine that counteracts the development of neuropathic pain after peripheral nerve damage. In conclusion, they indicate that immunotherapies based on IL-27 could emerge as possible therapeutic approaches for the prevention of neuropathic pain development after peripheral nerve injury. Neuroimmune–glia interactions have been implicated in the development of neuropathic pain. Interleukin-27 (IL-27) is a cytokine that presents regulatory activity in inflammatory conditions of the central nervous system. Thus, we hypothesized that IL-27 would participate in the neuropathic pain process. Here, we found that neuropathic pain caused by peripheral nerve injury (spared nerve injury model; SNI), was enhanced in IL-27-deficient(−/−) mice, whereas nociceptive pain is similar to that of wild-type mice. SNI induced an increase in the expression of IL-27 and its receptor subunit (Wsx1) in the sensory ganglia and spinal cord. IL-27 receptor was expressed mainly in resident macrophage, microglia, and astrocytes of the sensory ganglia and spinal cord, respectively. Finally, we identify that the antinociceptive effect of IL-27 was not observed in IL-10−/− mice. These results provided evidence that IL-27 is a cytokine produced after peripheral nerve injury that counteracts neuropathic pain development through induction of the antinociceptive cytokine IL-10. In summary, our study unraveled the role of IL-27 as a regulatory cytokine that counteracts the development of neuropathic pain after peripheral nerve damage. In conclusion, they indicate that immunotherapies based on IL-27 could emerge as possible therapeutic approaches for the prevention of neuropathic pain development after peripheral nerve injury. |
Author | Guimarães, Rafaela M Oliveira, Francisco F B Santa-Cecília, Flávia Alves-Filho, José C Davoli-Ferreira, Marcela Kusuda, Ricardo Ferreira, David W Cunha, Fernando Q Fonseca, Miriam M Cunha, Thiago M |
AuthorAffiliation | 1 Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP) , Ribeirão Preto , Brazil 2 Graduate Program in Basic and Applied Immunology, Ribeirão Preto Medical School, University of São Paulo (USP) , Ribeirão Preto , Brazil |
AuthorAffiliation_xml | – name: 1 Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP) , Ribeirão Preto , Brazil – name: 2 Graduate Program in Basic and Applied Immunology, Ribeirão Preto Medical School, University of São Paulo (USP) , Ribeirão Preto , Brazil |
Author_xml | – sequence: 1 givenname: Miriam M surname: Fonseca fullname: Fonseca, Miriam M organization: Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil – sequence: 2 givenname: Marcela surname: Davoli-Ferreira fullname: Davoli-Ferreira, Marcela organization: Graduate Program in Basic and Applied Immunology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil – sequence: 3 givenname: Flávia surname: Santa-Cecília fullname: Santa-Cecília, Flávia organization: Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil – sequence: 4 givenname: Rafaela M surname: Guimarães fullname: Guimarães, Rafaela M organization: Graduate Program in Basic and Applied Immunology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil – sequence: 5 givenname: Francisco F B surname: Oliveira fullname: Oliveira, Francisco F B organization: Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil – sequence: 6 givenname: Ricardo surname: Kusuda fullname: Kusuda, Ricardo organization: Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil – sequence: 7 givenname: David W surname: Ferreira fullname: Ferreira, David W organization: Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil – sequence: 8 givenname: José C surname: Alves-Filho fullname: Alves-Filho, José C organization: Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil – sequence: 9 givenname: Fernando Q surname: Cunha fullname: Cunha, Fernando Q organization: Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil – sequence: 10 givenname: Thiago M surname: Cunha fullname: Cunha, Thiago M organization: Department of Pharmacology, Center for Research in Inflammatory Diseases (CRID), Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, Brazil |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32047492$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkcFO3DAQQC1EVSjl3lOVYy_ZOh7HsS-Vqi3QSKu2B3q2JvZkNyiJt3aC1L8n7AKCuXhkz7wZ631gp2MYibFPBV8BaPO17YZhXglemBUHXpoTdl4oJXMQQp6-ys_YZUp3fAlpAKB8z85AcFlJI85ZXW9yUWXrMI8TRXRTyn7RHMMep13nsj_YjdkPuqc-7Acap-x2F8O83WX16Gc3dWHMQpstjIJ_ZO9a7BNdPp0X7O_11e36Z775fVOvv29yJ5WYctlUTrhGAtfe8VJjUVUKSQOWUgsNCpHQNY1ulx2FESSMl144apSWZVXBBauPXB_wzu5jN2D8bwN29nAR4tZinDrXkzVeGFUVy1wkCQYa5EiqLb1uwflCLqxvR9Z-bgbybvlhxP4N9O3L2O3sNtxbZUwFUiyAL0-AGP7NlCY7dMlR3-NIYU5WQCkLBZzrpZQfS10MKUVqX8YU3D4KtQeh9lGoPQhdWj6_Xu-l4VkfPAD5ZJ2g |
CitedBy_id | crossref_primary_10_1002_mnfr_202300378 crossref_primary_10_3390_ijms241612956 crossref_primary_10_3344_kjp_2022_35_3_271 crossref_primary_10_3390_biomedicines11020416 crossref_primary_10_1016_j_mcn_2023_103881 crossref_primary_10_1016_j_cyto_2021_155540 crossref_primary_10_1016_j_intimp_2020_107060 crossref_primary_10_1080_08830185_2024_2344170 crossref_primary_10_1007_s13311_020_00937_z crossref_primary_10_1128_JVI_00406_21 crossref_primary_10_1172_JCI153805 crossref_primary_10_1097_PR9_0000000000000873 crossref_primary_10_1097_j_pain_0000000000002695 crossref_primary_10_3390_jfmk9010031 crossref_primary_10_3389_fphar_2021_653852 crossref_primary_10_1002_mus_27812 crossref_primary_10_4103_1673_5374_336134 crossref_primary_10_3389_fimmu_2022_1012442 crossref_primary_10_3389_fpain_2024_1288024 crossref_primary_10_1002_iid3_1132 crossref_primary_10_3390_ijms232012389 crossref_primary_10_1007_s13311_021_01164_w crossref_primary_10_3390_fermentation9020167 crossref_primary_10_1093_cei_uxab025 |
Cites_doi | 10.1016/j.imlet.2008.01.011 10.1016/j.sjpain.2017.08.002 10.1016/j.celrep.2016.04.063 10.1038/s41598-018-29398-3 10.1111/j.1460-9568.2005.04057.x 10.1016/j.bbrc.2004.11.098 10.1189/jlb.0609445 10.4049/jimmunol.179.10.6421 10.1016/0304-3959(87)90041-8 10.1038/nrd4334 10.1016/0304-3959(94)90023-X 10.1080/14728222.2017.1328057 10.1016/S0014-2999(99)00790-6 10.1097/j.pain.0000000000001109 10.1038/ni1375 10.1016/S0304-3959(97)00148-6 10.4049/jimmunol.179.5.3268 10.1126/science.aaf8924 10.1146/annurev-immunol-032414-112134 10.1016/j.pain.2013.11.013 10.1186/ar3064 10.1016/j.pain.2014.09.016 10.1006/meth.2001.1262 10.1016/0006-8993(83)90849-1 10.1016/j.bbi.2018.06.015 10.1016/j.bbi.2006.10.012 10.1016/S0304-3959(00)00276-1 10.1590/S0100-879X2004000300018 10.1002/glia.22948 10.1038/nn.4053 10.1038/nri3621 10.1016/j.expneurol.2013.01.018 10.1016/j.pharmthera.2005.07.001 10.1016/j.jneuroim.2008.01.005 10.1016/S0306-4522(02)00065-9 10.1038/nrd1251 10.1016/j.jneuroim.2010.08.013 10.1016/j.cyto.2011.04.020 10.2147/JPR.S53660 10.1172/JCI80883 10.1016/j.bbi.2009.12.007 10.1128/MCB.20.11.4106-4114.2000 10.1002/art.30324 10.1038/nm.2123 10.1186/1742-2094-7-11 10.1016/j.cell.2009.09.028 10.1371/journal.pone.0028205 10.4049/jimmunol.174.12.7684 10.1213/01.ane.0000275190.42912.37 10.1111/j.1365-2567.2010.03379.x 10.1038/ni1540 10.1152/ajpgi.00329.2010 10.1111/j.1525-1403.2012.00462.x 10.1038/nn1992 10.1002/1529-0131(199904)42:4<710::AID-ANR14>3.0.CO;2-4 10.4049/jimmunol.172.4.2225 10.1016/j.bbi.2018.01.005 10.4049/jimmunol.1400058 10.1016/j.brainres.2011.10.016 10.1016/S1074-7613(02)00324-2 10.1097/j.pain.0000000000001383 10.1016/j.jns.2013.03.002 10.1038/nrn1700 10.4049/jimmunol.174.6.3534 10.1136/ard.2007.083360 10.1016/0092-8674(93)80068-P 10.1016/0304-3959(87)90088-1 10.1016/0304-3959(83)90201-4 10.1016/j.pain.2005.04.013 10.1016/j.neulet.2015.03.001 10.1073/pnas.252648899 10.1038/ncomms12029 10.1146/annurev.immunol.19.1.683 |
ContentType | Journal Article |
Copyright | Copyright © 2020 Fonseca, Davoli-Ferreira, Santa-Cecília, Guimarães, Oliveira, Kusuda, Ferreira, Alves-Filho, Cunha and Cunha. Copyright © 2020 Fonseca, Davoli-Ferreira, Santa-Cecília, Guimarães, Oliveira, Kusuda, Ferreira, Alves-Filho, Cunha and Cunha. 2020 Fonseca, Davoli-Ferreira, Santa-Cecília, Guimarães, Oliveira, Kusuda, Ferreira, Alves-Filho, Cunha and Cunha |
Copyright_xml | – notice: Copyright © 2020 Fonseca, Davoli-Ferreira, Santa-Cecília, Guimarães, Oliveira, Kusuda, Ferreira, Alves-Filho, Cunha and Cunha. – notice: Copyright © 2020 Fonseca, Davoli-Ferreira, Santa-Cecília, Guimarães, Oliveira, Kusuda, Ferreira, Alves-Filho, Cunha and Cunha. 2020 Fonseca, Davoli-Ferreira, Santa-Cecília, Guimarães, Oliveira, Kusuda, Ferreira, Alves-Filho, Cunha and Cunha |
DBID | NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3389/fimmu.2019.03059 |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1664-3224 |
EndPage | 3059 |
ExternalDocumentID | oai_doaj_org_article_9d29671462ae4393ba0ae6f5d8f3cd14 10_3389_fimmu_2019_03059 32047492 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Fundação de Amparo à Pesquisa do Estado de São Paulo grantid: 2013/08216-2 |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV DIK EBS EMOBN GROUPED_DOAJ GX1 HYE IAO IEA IHR IHW IPNFZ KQ8 M48 M~E NPM OK1 PGMZT RIG RNS RPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c462t-4b7c2cb4308dc058a1776ae83a5482836aaeacbb8f204292e29d4d2ceb6845773 |
IEDL.DBID | RPM |
ISSN | 1664-3224 |
IngestDate | Tue Oct 22 15:06:15 EDT 2024 Tue Sep 17 21:32:47 EDT 2024 Fri Oct 25 10:50:25 EDT 2024 Thu Sep 26 15:47:00 EDT 2024 Sat Sep 28 08:30:52 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | IL-27 glial cells macrophages neuropathic pain cytokines IL-10 |
Language | English |
License | Copyright © 2020 Fonseca, Davoli-Ferreira, Santa-Cecília, Guimarães, Oliveira, Kusuda, Ferreira, Alves-Filho, Cunha and Cunha. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-4b7c2cb4308dc058a1776ae83a5482836aaeacbb8f204292e29d4d2ceb6845773 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This article was submitted to Multiple Sclerosis and Neuroimmunology, a section of the journal Frontiers in Immunology Edited by: Felipe Almeida Pinho Ribeiro, Harvard Medical School, United States Present address: Miriam M. Fonseca, Pain Mechanisms Laboratory, Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC, United States Reviewed by: Felipe J. Nobre Lelis, Brigham and Women's Hospital and Harvard Medical School, United States; Rafael Gonzalez-Cano, Boston Children's Hospital and Harvard Medical School, United States; Larissa Staurengo-Ferrari, University of California, San Francisco, United States |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997342/ |
PMID | 32047492 |
PQID | 2354163008 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_9d29671462ae4393ba0ae6f5d8f3cd14 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6997342 proquest_miscellaneous_2354163008 crossref_primary_10_3389_fimmu_2019_03059 pubmed_primary_32047492 |
PublicationCentury | 2000 |
PublicationDate | 2020-01-28 |
PublicationDateYYYYMMDD | 2020-01-28 |
PublicationDate_xml | – month: 01 year: 2020 text: 2020-01-28 day: 28 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in immunology |
PublicationTitleAlternate | Front Immunol |
PublicationYear | 2020 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Ribeiro (B42) 2000; 387 Livak (B44) 2001; 25 Milligan (B51) 2012; 15 Hölscher (B27) 2005; 174 Ji (B6) 2014; 13 Kühn (B35) 1993; 75 Shen (B70) 2013; 247 Watkins (B10) 2003; 2 Marchand (B2) 2005; 6 van Hecke (B1) 2014; 155 Xu (B12) 2010; 16 Stumhofer (B25) 2008; 117 Jancálek (B50) 2010; 7 Grace (B3) 2014; 14 Villarino (B24) 2005; 174 Hung (B52) 2017; 17 de Aquino (B29) 2014; 193 Papir-Kricheli (B43) 1987; 31 Liu (B8) 2012; 1427 Janes (B67) 2014; 155 Hu (B7) 2002; 112 Berta (B55) 2017; 21 Jung (B36) 2000; 20 Sénécal (B21) 2016; 64 Lee (B20) 2011; 132 Choi (B40) 1994; 59 Denk (B56) 2016; 15 Decosterd (B37) 2000; 87 Sasaoka (B73) 2011; 300 Ledeboer (B63) 2007; 21 Khan (B15) 2015; 592 Pflanz (B18) 2004; 172 Wang (B60) 2007; 179 Wu (B69) 2018; 73 Yoshida (B22) 2015; 33 Scholz (B58) 2007; 10 Rostami (B72) 2013; 333 Thacker (B53) 2007; 105 Clark (B54) 2013; 6 Milligan (B49) 2005; 21 Cunha (B41) 2004; 37 Pflanz (B17) 2002; 16 Nieuwenhuis (B34) 2002; 99 Helmark (B66) 2010; 12 Peng (B9) 2016; 7 Moore (B71) 2001; 19 Santa-Cecília (B46) 2009; 160 Hunskaar (B38) 1987; 30 Scheller (B59) 2005; 326 Sasaguri (B19) 2018; 8 Pickens (B32) 2011; 63 Wagner (B64) 1998; 74 Sorge (B45) 2015; 18 Chen (B14) 2015; 125 Alexander (B61) 2005; 116 Inoue (B11) 2006; 109 Yoshida (B26) 2009; 86 Fitzgerald (B30) 2007; 179 Austin (B47) 2010; 229 Kwilasz (B68) 2018; 69 Lee (B48) 2004; 15 Üçeyler (B13) 2011; 6 Kuraishi (B39) 1983; 273 Whitehead (B57) 2010; 24 Backonja (B62) 2008; 195 Basbaum (B5) 2009; 139 Alaaeddine (B65) 1999; 42 Bobinski (B16) 2018; 159 Tanida (B33) 2011; 55 Ji (B4) 2016; 354 Fitzgerald (B23) 2007; 8 Batten (B28) 2006; 7 Niedbala (B31) 2008; 37 Zimmermann (B74) 1983; 16 |
References_xml | – volume: 117 start-page: 23 year: 2008 ident: B25 article-title: Advances in understanding the anti-inflammatory properties of IL-27 publication-title: Immunol Lett. doi: 10.1016/j.imlet.2008.01.011 contributor: fullname: Stumhofer – volume: 17 start-page: 287 year: 2017 ident: B52 article-title: Targeting cytokines for treatment of neuropathic pain publication-title: Scand J Pain. doi: 10.1016/j.sjpain.2017.08.002 contributor: fullname: Hung – volume: 15 start-page: 1771 year: 2016 ident: B56 article-title: Persistent alterations in microglial enhancers in a model of chronic pain publication-title: Cell Rep. doi: 10.1016/j.celrep.2016.04.063 contributor: fullname: Denk – volume: 8 start-page: 11022 year: 2018 ident: B19 article-title: Interleukin-27 controls basal pain threshold in physiological and pathological conditions publication-title: Sci Rep. doi: 10.1038/s41598-018-29398-3 contributor: fullname: Sasaguri – volume: 21 start-page: 2136 year: 2005 ident: B49 article-title: Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10 publication-title: Eur J Neurosci. doi: 10.1111/j.1460-9568.2005.04057.x contributor: fullname: Milligan – volume: 326 start-page: 724 year: 2005 ident: B59 article-title: No inhibition of IL-27 signaling by soluble gp130 publication-title: Biochem Biophys Res Commun. doi: 10.1016/j.bbrc.2004.11.098 contributor: fullname: Scheller – volume: 86 start-page: 1295 year: 2009 ident: B26 article-title: Interleukin 27: a double-edged sword for offense and defense publication-title: J Leukoc Biol. doi: 10.1189/jlb.0609445 contributor: fullname: Yoshida – volume: 179 start-page: 6421 year: 2007 ident: B60 article-title: Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1(IL-27R) deficiency publication-title: J Immunol. doi: 10.4049/jimmunol.179.10.6421 contributor: fullname: Wang – volume: 31 start-page: 263 year: 1987 ident: B43 article-title: Behavioural effects of receptor-specific substance P agonists publication-title: Pain. doi: 10.1016/0304-3959(87)90041-8 contributor: fullname: Papir-Kricheli – volume: 13 start-page: 533 year: 2014 ident: B6 article-title: Emerging targets in neuroinflammation-driven chronic pain publication-title: Nat Rev Drug Discov. doi: 10.1038/nrd4334 contributor: fullname: Ji – volume: 59 start-page: 369 year: 1994 ident: B40 article-title: Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain publication-title: Pain. doi: 10.1016/0304-3959(94)90023-X contributor: fullname: Choi – volume: 21 start-page: 695 year: 2017 ident: B55 article-title: Targeting dorsal root ganglia and primary sensory neurons for the treatment of chronic pain publication-title: Expert Opin Ther Targets. doi: 10.1080/14728222.2017.1328057 contributor: fullname: Berta – volume: 387 start-page: 111 year: 2000 ident: B42 article-title: Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice publication-title: Eur J Pharmacol. doi: 10.1016/S0014-2999(99)00790-6 contributor: fullname: Ribeiro – volume: 159 start-page: 437 year: 2018 ident: B16 article-title: Interleukin-4 mediates the analgesia produced by low-intensity exercise in mice with neuropathic pain publication-title: Pain. doi: 10.1097/j.pain.0000000000001109 contributor: fullname: Bobinski – volume: 7 start-page: 929 year: 2006 ident: B28 article-title: Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells publication-title: Nat Immunol. doi: 10.1038/ni1375 contributor: fullname: Batten – volume: 15 start-page: 2807 year: 2004 ident: B48 article-title: Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model publication-title: Neuroreport. contributor: fullname: Lee – volume: 74 start-page: 35 year: 1998 ident: B64 article-title: Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression publication-title: Pain. doi: 10.1016/S0304-3959(97)00148-6 contributor: fullname: Wagner – volume: 179 start-page: 3268 year: 2007 ident: B30 article-title: Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis publication-title: J Immunol. doi: 10.4049/jimmunol.179.5.3268 contributor: fullname: Fitzgerald – volume: 354 start-page: 572 year: 2016 ident: B4 article-title: Pain regulation by non-neuronal cells and inflammation publication-title: Science. doi: 10.1126/science.aaf8924 contributor: fullname: Ji – volume: 33 start-page: 417 year: 2015 ident: B22 article-title: The immunobiology of interleukin-27 publication-title: Annu Rev Immunol. doi: 10.1146/annurev-immunol-032414-112134 contributor: fullname: Yoshida – volume: 155 start-page: 654 year: 2014 ident: B1 article-title: Neuropathic pain in the general population: a systematic review of epidemiological studies publication-title: Pain. doi: 10.1016/j.pain.2013.11.013 contributor: fullname: van Hecke – volume: 12 start-page: R126 year: 2010 ident: B66 article-title: Exercise increases interleukin-10 levels both intraarticularly and peri-synovially in patients with knee osteoarthritis: a randomized controlled trial publication-title: Arthritis Res Ther. doi: 10.1186/ar3064 contributor: fullname: Helmark – volume: 155 start-page: 2560 year: 2014 ident: B67 article-title: A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways publication-title: Pain. doi: 10.1016/j.pain.2014.09.016 contributor: fullname: Janes – volume: 25 start-page: 402 year: 2001 ident: B44 article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2[-delta delta C(T)] method publication-title: Methods. doi: 10.1006/meth.2001.1262 contributor: fullname: Livak – volume: 273 start-page: 245 year: 1983 ident: B39 article-title: Separate involvement of the spinal noradrenergic and serotonergic systems in morphine analgesia: the differences in mechanical and thermal algesic tests publication-title: Brain Res doi: 10.1016/0006-8993(83)90849-1 contributor: fullname: Kuraishi – volume: 73 start-page: 504 year: 2018 ident: B69 article-title: Spinal interleukin-10 produces antinociception in neuropathy through microglial β-endorphin expression, separated from antineuroinflammation publication-title: Brain Behav Immun. doi: 10.1016/j.bbi.2018.06.015 contributor: fullname: Wu – volume: 21 start-page: 686 year: 2007 ident: B63 article-title: Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats publication-title: Brain Behav Immun. doi: 10.1016/j.bbi.2006.10.012 contributor: fullname: Ledeboer – volume: 87 start-page: 149 year: 2000 ident: B37 article-title: Spared nerve injury: an animal model of persistent peripheral neuropathic pain publication-title: Pain. doi: 10.1016/S0304-3959(00)00276-1 contributor: fullname: Decosterd – volume: 37 start-page: 401 year: 2004 ident: B41 article-title: An electronic pressure-meter nociception paw test for mice publication-title: Braz J Med Biol Res. doi: 10.1590/S0100-879X2004000300018 contributor: fullname: Cunha – volume: 64 start-page: 553 year: 2016 ident: B21 article-title: Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: modulation of local immune responses publication-title: Glia. doi: 10.1002/glia.22948 contributor: fullname: Sénécal – volume: 18 start-page: 1081 year: 2015 ident: B45 article-title: Different immune cells mediate mechanical pain hypersensitivity in male and female mice publication-title: Nat Neurosci. doi: 10.1038/nn.4053 contributor: fullname: Sorge – volume: 14 start-page: 217 year: 2014 ident: B3 article-title: Pathological pain and the neuroimmune interface publication-title: Nat Rev Immunol. doi: 10.1038/nri3621 contributor: fullname: Grace – volume: 247 start-page: 466 year: 2013 ident: B70 article-title: Interleukin-10 down-regulates voltage gated sodium channels in rat dorsal root ganglion neurons publication-title: Exp Neurol. doi: 10.1016/j.expneurol.2013.01.018 contributor: fullname: Shen – volume: 109 start-page: 210 year: 2006 ident: B11 article-title: The function of microglia through purinergic receptors: neuropathic pain and cytokine release publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2005.07.001 contributor: fullname: Inoue – volume: 195 start-page: 157 year: 2008 ident: B62 article-title: Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients publication-title: J Neuroimmunol doi: 10.1016/j.jneuroim.2008.01.005 contributor: fullname: Backonja – volume: 112 start-page: 23 year: 2002 ident: B7 article-title: Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat publication-title: Neuroscience. doi: 10.1016/S0306-4522(02)00065-9 contributor: fullname: Hu – volume: 2 start-page: 973 year: 2003 ident: B10 article-title: Glia: a novel drug discovery target for clinical pain publication-title: Nat Rev Drug Discov. doi: 10.1038/nrd1251 contributor: fullname: Watkins – volume: 229 start-page: 26 year: 2010 ident: B47 article-title: The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines publication-title: J Neuroimmunol. doi: 10.1016/j.jneuroim.2010.08.013 contributor: fullname: Austin – volume: 55 start-page: 237 year: 2011 ident: B33 article-title: IL-27-producing CD14(+) cells infiltrate inflamed joints of rheumatoid arthritis and regulate inflammation and chemotactic migration publication-title: Cytokine doi: 10.1016/j.cyto.2011.04.020 contributor: fullname: Tanida – volume: 6 start-page: 803 year: 2013 ident: B54 article-title: Neuropathic pain and cytokines: current perspectives publication-title: J Pain Res. doi: 10.2147/JPR.S53660 contributor: fullname: Clark – volume: 125 start-page: 3226 year: 2015 ident: B14 article-title: Intrathecal bone marrow stromal cells inhibit neuropathic pain via TGF-β secretion publication-title: J Clin Invest. doi: 10.1172/JCI80883 contributor: fullname: Chen – volume: 24 start-page: 569 year: 2010 ident: B57 article-title: Dynamic regulation of spinal pro-inflammatory cytokine release in the rat in vivo following peripheral nerve injury publication-title: Brain Behav Immun. doi: 10.1016/j.bbi.2009.12.007 contributor: fullname: Whitehead – volume: 20 start-page: 4106 year: 2000 ident: B36 article-title: Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion publication-title: Mol Cell Bio. doi: 10.1128/MCB.20.11.4106-4114.2000 contributor: fullname: Jung – volume: 63 start-page: 2289 year: 2011 ident: B32 article-title: Local expression of interleukin-27 ameliorates collagen-induced arthritis publication-title: Arthritis Rheum. doi: 10.1002/art.30324 contributor: fullname: Pickens – volume: 16 start-page: 592 year: 2010 ident: B12 article-title: Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions publication-title: Nat Med. doi: 10.1038/nm.2123 contributor: fullname: Xu – volume: 7 start-page: 11 year: 2010 ident: B50 article-title: Bilateral changes of TNF-alpha and IL-10 protein in the lumbar and cervical dorsal root ganglia following a unilateral chronic constriction injury of the sciatic nerve publication-title: J Neuroinflam. doi: 10.1186/1742-2094-7-11 contributor: fullname: Jancálek – volume: 139 start-page: 267 year: 2009 ident: B5 article-title: Cellular and molecular mechanisms of pain publication-title: Cell. doi: 10.1016/j.cell.2009.09.028 contributor: fullname: Basbaum – volume: 6 start-page: e28205 year: 2011 ident: B13 article-title: IL-4 deficiency is associated with mechanical hypersensitivity in mice publication-title: PLoS ONE. doi: 10.1371/journal.pone.0028205 contributor: fullname: Üçeyler – volume: 174 start-page: 7684 year: 2005 ident: B24 article-title: Positive and negative regulation of the IL-27 receptor during lymphoid cell activation publication-title: J Immunol. doi: 10.4049/jimmunol.174.12.7684 contributor: fullname: Villarino – volume: 105 start-page: 838 year: 2007 ident: B53 article-title: Pathophysiology of peripheral neuropathic pain: immune cells and molecules publication-title: Anesth Analg. doi: 10.1213/01.ane.0000275190.42912.37 contributor: fullname: Thacker – volume: 132 start-page: 492 year: 2011 ident: B20 article-title: Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10 publication-title: Immunology. doi: 10.1111/j.1365-2567.2010.03379.x contributor: fullname: Lee – volume: 8 start-page: 1372 year: 2007 ident: B23 article-title: Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells publication-title: Nat Immunol. doi: 10.1038/ni1540 contributor: fullname: Fitzgerald – volume: 300 start-page: G568 year: 2011 ident: B73 article-title: Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells publication-title: Am J Physiol Gastrointest Liver Physiol. doi: 10.1152/ajpgi.00329.2010 contributor: fullname: Sasaoka – volume: 15 start-page: 520 year: 2012 ident: B51 article-title: Spinal interleukin-10 therapy to treat peripheral neuropathic pain publication-title: Neuromodulation. doi: 10.1111/j.1525-1403.2012.00462.x contributor: fullname: Milligan – volume: 10 start-page: 1361 year: 2007 ident: B58 article-title: The neuropathic pain triad: neurons, immune cells and glia publication-title: Nat Neurosci. doi: 10.1038/nn1992 contributor: fullname: Scholz – volume: 42 start-page: 710 year: 1999 ident: B65 article-title: Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways publication-title: Arthritis Rheum doi: 10.1002/1529-0131(199904)42:4<710::AID-ANR14>3.0.CO;2-4 contributor: fullname: Alaaeddine – volume: 172 start-page: 2225 year: 2004 ident: B18 article-title: WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27 publication-title: J Immunol. doi: 10.4049/jimmunol.172.4.2225 contributor: fullname: Pflanz – volume: 69 start-page: 470 year: 2018 ident: B68 article-title: Sustained reversal of central neuropathic pain induced by a single intrathecal injection of adenosine A2A receptor agonists publication-title: Brain Behav Immun. doi: 10.1016/j.bbi.2018.01.005 contributor: fullname: Kwilasz – volume: 193 start-page: 285 year: 2014 ident: B29 article-title: IL-27 limits central nervous system viral clearance by promoting IL-10 and enhances demyelination publication-title: J Immunol. doi: 10.4049/jimmunol.1400058 contributor: fullname: de Aquino – volume: 1427 start-page: 65 year: 2012 ident: B8 article-title: Activation of satellite glial cells in lumbar dorsal root ganglia contributes to neuropathic pain after spinal nerve ligation publication-title: Brain Res. doi: 10.1016/j.brainres.2011.10.016 contributor: fullname: Liu – volume: 16 start-page: 779 year: 2002 ident: B17 article-title: IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells publication-title: Immunity. doi: 10.1016/S1074-7613(02)00324-2 contributor: fullname: Pflanz – volume: 160 start-page: 102 year: 2009 ident: B46 article-title: The NOD2 signaling in peripheral macrophages contributes to neuropathic pain development publication-title: Pain. doi: 10.1097/j.pain.0000000000001383 contributor: fullname: Santa-Cecília – volume: 333 start-page: 76 year: 2013 ident: B72 article-title: Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination publication-title: J Neurol Sci doi: 10.1016/j.jns.2013.03.002 contributor: fullname: Rostami – volume: 6 start-page: 521 year: 2005 ident: B2 article-title: Role of the immune system in chronic pain publication-title: Nat Rev Neurosci. doi: 10.1038/nrn1700 contributor: fullname: Marchand – volume: 174 start-page: 3534 year: 2005 ident: B27 article-title: The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis publication-title: J Immunol. doi: 10.4049/jimmunol.174.6.3534 contributor: fullname: Hölscher – volume: 37 start-page: 1474 year: 2008 ident: B31 article-title: Interleukin 27 attenuates collagen-induced arthritis publication-title: Ann Rheum Dis. doi: 10.1136/ard.2007.083360 contributor: fullname: Niedbala – volume: 75 start-page: 263 year: 1993 ident: B35 article-title: Interleukin-10-deficient mice develop chronic enterocolitis publication-title: Cell. doi: 10.1016/0092-8674(93)80068-P contributor: fullname: Kühn – volume: 30 start-page: 103 year: 1987 ident: B38 article-title: The formalin test in mice: dissociation between inflammatory and non-inflammatory pain publication-title: Pain. doi: 10.1016/0304-3959(87)90088-1 contributor: fullname: Hunskaar – volume: 16 start-page: 109 year: 1983 ident: B74 article-title: Ethical guidelines for investigations of experimental pain in conscious animals publication-title: Pain. doi: 10.1016/0304-3959(83)90201-4 contributor: fullname: Zimmermann – volume: 116 start-page: 213 year: 2005 ident: B61 article-title: Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS publication-title: Pain. doi: 10.1016/j.pain.2005.04.013 contributor: fullname: Alexander – volume: 592 start-page: 99 year: 2015 ident: B15 article-title: Interleukin-10 levels in rat models of nerve damage and neuropathic pain publication-title: Neurosci Lett. doi: 10.1016/j.neulet.2015.03.001 contributor: fullname: Khan – volume: 99 start-page: 16951 year: 2002 ident: B34 article-title: Disruption of T helper 2-immune responses in epstein–barr virus-induced Gene 3-deficient mice publication-title: Proc Natl Acad Sci USA. doi: 10.1073/pnas.252648899 contributor: fullname: Nieuwenhuis – volume: 7 start-page: 1 year: 2016 ident: B9 article-title: Microglia and monocytes synergistically promote the transition from acute to chronic pain after nerve injury publication-title: Nat Commun. doi: 10.1038/ncomms12029 contributor: fullname: Peng – volume: 19 start-page: 683 year: 2001 ident: B71 article-title: Interleukin-10 and the interleukin-10 receptor publication-title: Annu Rev Immunol. doi: 10.1146/annurev.immunol.19.1.683 contributor: fullname: Moore |
SSID | ssj0000493335 |
Score | 2.4178817 |
Snippet | Neuroimmune-glia interactions have been implicated in the development of neuropathic pain. Interleukin-27 (IL-27) is a cytokine that presents regulatory... Neuroimmune–glia interactions have been implicated in the development of neuropathic pain. Interleukin-27 (IL-27) is a cytokine that presents regulatory... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 3059 |
SubjectTerms | cytokines glial cells IL-10 IL-27 Immunology macrophages neuropathic pain |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS91AFB6KUOhGah8a-2AEN10EkzPPLG2peEuVLhTcDfNEC-aK3rvov--ZmXslV4Ruuk1CMvnOJOf7mDPfIeRQcNY5CLKNHpUOjzy02gqNP0MhIHLhfakmPDuXp5f8x5W4mrT6yjVh1R64Anc0BBikwu8ZbMTkyZztbJRJBJ2YD311Au1gIqZ-V97LGBN1XRJV2HCUbm5vl7mUK5uaFmvSSR4qdv3PccynpZKT3HPymmyvSCM9roPdIS_i-Ia8rG0k_7wls9nPFhTN28vzfmK_eKDFc6N0G_b0F4p_OikOohe1Nw_NbTvKtgY6TxTv0XfvyOXJ94tvp-2qRULrEZFFy53y4B0CroPvhLa9UtJGzSwqEWQO0lr8szqnE-TMAxGGwAP46KTmQin2nmyN8zHuEeolA5eQPVmVuMu2dl2fgk-D9EjLfGjIlzVg5q46YRhUEBlcU8A1GVxTwG3I14zo43XZw7ocwMiaVWTNvyLbkIN1PAzO-byQYcc4Xz4YYCLzSKQvDdmt8Xl8FMMXVXyAhqiNyG2MZfPMeHNdfLXlMCjGYf9_DP4DeQVZmXd9C_oj2VrcL-MnpC8L97nM1L-7oO0N priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Lb9QwELagCNQL4t3wkpG4cAgk42cOCAGiahFFHLpSb5afZRHNln1I9N8zdrKli5ZrHk70je35Rp75hpCXgrPGQZB19Bjp8MhDra3QuBkKAZEL70s24dFXeTDhn0_Eyd_y6BHAxdbQLveTmsx_vv796-IdLvi3OeJEf_smTc_OVjlLK-uVIl24Tm4A-sWc4HU0kv0fAxdmjInhrHLri7vkFoOGK97Bhpsqav7bKOi_mZRXXNP-HXJ75JT0_TAJ7pJrsb9Hbg5dJi_uk8PDLzUomqvPc7mxXy5okeQozYg9_WanPb2SO0SPh9Y9NHf1KFUPdJYojtE2D8hk_9Pxx4N67KBQey5hWXOnPHiH9tDBN0LbVilpo2YWAxUkFtJa3Hid0wmyY4IIXeABfHRSc6EUe0h2-lkf9wj1koFLSK6sStxl1bumTcGnTnpkbT5U5NUaMHM-CGUYDDAyzqbgbDLOpuBckQ8Z0cvnssR1uTCbn5pxxZguQCcVbuRgI7Im5mxjo0wi6MR8aHlFXqztYXBJ5HMO28fZamGAiUwzkd1U5NFgn8tPre1bEbVhuY1_2bzTT78X2W3ZdYpxePzfMZ-QXcjReNPWoJ-SneV8FZ8hZVm652Um_gFzhuf3 priority: 102 providerName: Scholars Portal |
Title | IL-27 Counteracts Neuropathic Pain Development Through Induction of IL-10 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32047492 https://search.proquest.com/docview/2354163008 https://pubmed.ncbi.nlm.nih.gov/PMC6997342 https://doaj.org/article/9d29671462ae4393ba0ae6f5d8f3cd14 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxNBDLbaSqBeEG-WRzVIXDhsszvvPUJFaRFBPbRSbqN5QhDZVG1y4N_jmc1WCeLEZQ77HNmW_Vnz2QZ4JzhrHA2yjh4zHR55qLUVGp2hEDRy4X1hE06_ybMr_mUmZnsgxlqYQtr3bn7c_1oc9_MfhVt5vfCTkSc2uZieyK5TjNPJPuxj-N1K0X8OkJcxJoYjSUzAukmaLxbrzOLK_UwRThzCfUYbrnhHd6JRadr_L6T5N2FyKwKdPoQHG-hIPgxbfAR7sX8M94Zhkr-fwPn515oqkovMc1WxX92S0nmjzBz25MLOe7JFESKXw4Qekod3lOIGskwEv9E2T-Hq9NPlyVm9GZRQey7pquZOeeodil0H3whtW6WkjZpZzEcQP0hr0b86pxPN8YdG2gUeqI9Oai6UYs_goF_28QUQLxl1CTGUVYm73NyuaVPwqZMewZkPFbwfBWauh34YBvOILGdT5GyynE2RcwUfs0TvnsudrMuF5c13s9Gn6QLtpEJ_TW1EcMScbWyUSQSdmA8tr-DtqA-Dlp-PM2wfl-tbQ5nIaBJBTAXPB_3c_WrUbwVqR3M7e9m9g8ZWumtvjOvlf7_5Cg5pTsqbtqb6NRysbtbxDSKXlTsqGT-un2ctrlOuj4rt_gFDR_A6 |
link.rule.ids | 230,314,727,780,784,864,885,2102,24318,27924,27925,53791,53793 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxEB6VImgvqLzKQgtG4sJhm12_fYSKKoGk6iGVerP82hJENlWbHPj32N5slaCeuO7T-mY0_kb-ZgbgE6OkstjzMriY6dBAfSkNkzEYMoYDZc5lNeHknA8v6fcrdrUDrK-FyaJ9Z2cn7e_5STv7mbWVN3M36HVig4vJKVdKEIoHj-AxI0LVG0n6r470EkJYdygZUzA1aGbz-SrpuFJH00go9uEpwRUVVOGt_Si37X-Ia_4rmdzYg84O4NmaPKIv3SKfw05oX8CTbpzkn5cwGo1LLFAqM091xW55h3LvjTx12KELM2vRhkgITbsZPSiN78jlDWjRoPiNunoFl2ffpqfDcj0qoXSU42VJrXDY2Qi89K5i0tRCcBMkMTEjiQyCGxMjrLWywWkHwgErTz12wXJJmRDkNey2iza8AeQ4wbaJLMqIhtrU3q6qG-8axV2kZ84X8LkHTN90HTF0zCQSzjrjrBPOOuNcwNeE6P1zqZd1vrC4vdZri2rlseIiRmxsQqRHxJrKBN4wLxvifE0L-NjbQ0ffTwcapg2L1Z3GhCU-GWlMAYedfe5_1du3ALFlua21bN-J7pb7a6_d6-1_v_kB9obTyViPR-c_3sE-Til6VZdYHsHu8nYVjiOPWdr32Wv_Ah-Y8M8 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxEB5BEVUviDfL00hcOGx318_dIxSiBtoqh1bqzfKzBJFN1CYH_j1jb1IliBPXfVrfjOxv5M_fAHwQnNWWelkGh5UOD9yXrREtToZC0MCFc1lNeHomjy_4t0txudXqK4v2nZ0e9r9mh_30R9ZWLmau2ujEqsnpkew6xTitFj5Wd-GeYJhkW4X6z4H4MsbEsDGJZVhXxelstkparuRqiqTiAPYZrbniHd1Zk7J1_7_45t-yya11aPQQHqwJJPk0DPQR3An9Y7g_tJT8_QTG45OSKpKOmqezxW55Q7L_Ru487MjETHuyJRQi50OfHpJaeOQjDmQeCX6jqZ_Cxejr-dFxuW6XUDou6bLkVjnqLILfeleL1jRKSRNaZrAqQRYhjcFZ1to20rQK0UA7zz11wcqWC6XYM9jr5314AcRJRm1EJmVU5DZZ3NVN9C520iFFc76AjxvA9GJwxdBYTSScdcZZJ5x1xrmAzwnR2-eSn3W-ML--0uuo6s7TTiqctakJSJGYNbUJMgrfRuZ8wwt4v4mHxvxPmxqmD_PVjaZMJE6JVKaA50N8bn-1iW8BaidyO2PZvYMplz221yn28r_ffAf7ky8jfTI--_4KDmiq0uumpO1r2Fter8IbpDJL-zYn7R-c-_Hi |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IL-27+Counteracts+Neuropathic+Pain+Development+Through+Induction+of+IL-10&rft.jtitle=Frontiers+in+immunology&rft.au=Fonseca%2C+Miriam+M&rft.au=Davoli-Ferreira%2C+Marcela&rft.au=Santa-Cec%C3%ADlia%2C+Fl%C3%A1via&rft.au=Guimar%C3%A3es%2C+Rafaela+M&rft.date=2020-01-28&rft.eissn=1664-3224&rft.volume=10&rft.spage=3059&rft_id=info:doi/10.3389%2Ffimmu.2019.03059&rft_id=info%3Apmid%2F32047492&rft.externalDocID=32047492 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon |